Synaptogenix Inc (NASDAQ:SNPX) finished Wednesday with an addition of $0.04 to close at $0.42, an upside of 10.50 percent. An average of 4,240,020 shares of common stock have been traded in the last five days. There was a gain of $0.1437 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 1,889,690 shares traded, while the 50-day average volume stands at 945,830.
SNPX stock has decreased by -18.49% in the last month. The company shares reached their 1-month lowest point of $0.2650 on 09/19/23. With the stock rallying to its 52-week high on 07/13/23, shares of the company touched a low of $0.26 and a high of $7.73 in 52 weeks. It has reached a new high 8 times so far this year and lost -63.79% or -$0.7400 in price. In spite of this, the price is down -94.57% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
SNPX stock investors should be aware that Synaptogenix Inc (SNPX) stock had its last reported insider trading activity 286 days ago on Dec 16. In this transaction, the insider spent $31,641. Chief Financial Officer, WEINSTEIN ROBERT, disposed of 27,000 shares at a price of $1.17 on Dec 16. The insider now owns more than $31,641 worth of shares. Prior to that, Director Singer William S. went on to Sale 27,000 shares at $1.17 each on Dec 16. An amount of $31,641 was transacted.
Valuation Metrics
Synaptogenix Inc (SNPX) stock’s beta is 1.74. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.12.
Financial Health
The quick ratio of Synaptogenix Inc for the three months ended March 30 was 12.05, and the current ratio was 12.05, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30.
Earnings Surprise
The company posted a net income of $10.21 million in the quarter, while revenues of $1.98 million were grew 63.27%. The analyst consensus anticipated Synaptogenix Inc’s latest quarter earnings to come in at -$0.56 per share, but it turned out to be -$0.26, a 53.60% surprise. At the end of the quarter ending March 30, Synaptogenix Inc’s stock balance sheet showed total liabilities of 6.53 million. Shareholders own equity worth $10.16 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Synaptogenix Inc (SNPX) price momentum. RSI 9-day as of the close on 27 September was 60.82%, suggesting the stock is Neutral, with historical volatility in this time frame at 163.49%.
As of today, SNPX’s price is $0.3610 +52.01% or $0.1437 from its 5-day moving average. SNPX is currently trading -19.45% lower than its 20-day SMA and -50.65% lower than its 100-day SMA. However, the stock’s current price level is -53.80% below the SMA50 and -92.15% below the SMA200.
The stochastic %K and %D were 55.91% and 40.42%, respectively, and the average true range (ATR) was 0.0626. With the 14-day stochastic at 88.57% and the average true range at 0.0621, the RSI (14) stands at 49.52%. The stock has reached 0.0549 on the 9-day MACD Oscillator while the 14-day reading was at 0.0504.
Analyst Ratings
The consensus rating for Synaptogenix Inc (SNPX) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SNPX, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.
What is SNPX’s price target for the next 12 months?
Analysts predict a range of price targets between $14.00 and $14.00, with a median target of $14.00. Taking a look at these predictions, the average price target given by analysts for Synaptogenix Inc (SNPX) stock is $14.00.
